Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and sézary syndrome: The InterLymph non-Hodgkin lymphoma subtypes project

Journal of the National Cancer Institute - Monographs

Volumn , Issue 48, 2014, Pages 98-105

  Aschebrook Kilfoy, Briseis ^a   Cocco, Pierluigi ^b   La Vecchia, Carlo ^c,d   Chang, Ellen T ^e,o   Vajdic, Claire M ^f   Kadin, Marshall E ^g,p   Spinelli, John J ^h,q   Morton, Lindsay M ⁱ   Kane, Eleanor V ^j   Sampson, Joshua N ⁱ   Kasten, Carol ^k   Feldman, Andrew L ^l   Wang, Sophia S ^m   Zhang, Yawei ⁿ  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e EXPONENT INC   (United States)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j UNIVERSITY OF YORK   (United Kingdom)

^k MASSACHUSETTS GENERAL HOSPITAL   (United States)

^l MAYO CLINIC CANCER CENTER   (United States)

^m CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

ⁿ YALE UNIVERSITY   (United States)

^o STANFORD UNIVERSITY   (United States)

^p ROGER WILLIAMS MEDICAL CENTER   (United States)

^q UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGRICULTURAL WORKER; ARTICLE; AUTOIMMUNE DISEASE; BLOOD TRANSFUSION REACTION; BODY MASS; CARPENTER; CASE CONTROL STUDY; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; ECZEMA; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HEPATITIS C; HORMONE SUBSTITUTION; HUMAN; INFLAMMATORY BOWEL DISEASE; LEISURE; LIFESTYLE; MALE; MEDICAL HISTORY; MULTIPLE MYELOMA; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; ORAL CONTRACEPTIVE USE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSORIASIS; RARE DISEASE; SEZARY SYNDROME; SMOKING; VERY ELDERLY; AUSTRALIA; DISEASE ASSOCIATION; EUROPE; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORTH AMERICA; OCCUPATIONAL HAZARD; PAINTER; SOCIAL STATUS; COMORBIDITY; ETHNOLOGY; META ANALYSIS; MIDDLE AGED; RISK; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CASE-CONTROL STUDIES; COMORBIDITY; EUROPE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NORTH AMERICA; OCCUPATIONAL EXPOSURE; ODDS RATIO; RISK FACTORS; SEZARY SYNDROME; YOUNG ADULT;

EID: 84906836320     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgu008     Document Type: Article

References (45)

1. Bradford PT, Devesa SS, Anderson WF, Toro JR. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood. 2009;113(21):5064-5073.
2. Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma. 2013;54(4):752-759.
3. Saunes M, Nilsen TI, Johannesen TB. Incidence of primary cutaneous T-cell lymphoma in Norway. Br J Dermatol. 2009;160(2):376-379.
4. Ishihara K, Saida T, Otsuka F, Yamazaki N. Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol. 2008;13(1):33-41.
5. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon, France: IARC Press; 2001.
6. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730-4739.
7. Talpur R, Singh L, Daulat S, et al. Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clin Cancer Res. 2012;18(18):5051-5060.
8. Criscione VD, Weinstock MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002. Arch Dermatol. 2007;143(7):854-859.
9. Whittemore AS, Holly EA, Lee IM, et al. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. J Natl Cancer Inst. 1989;81(20):1560-1567.
10. Morales-Suarez-Varela MM, Olsen J, Johansen P, et al. Occupational exposures and mycosis fungoides. A European multicentre case-control study (Europe). Cancer Causes Control. 2005;16(10):1253-1259.
11. Linet MS, McLaughlin JK, Fraumeni JF Jr, Malker HS, Weiner JA, Ericsson JL. Mycosis fungoides and occupation in Sweden. J Natl Cancer Inst. 1989;81(23):1842-1843.
12. Morales-Suarez-Varela MM, Olsen J, Villeneuve S, et al. Occupational exposure to chlorinated and petroleum solvents and mycosis fungoides. J Occup Environ Med. 2013;55(8):924-31.
13. Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-6489.
14. Morales-Suarez-Varela MM, Olsen J, Johansen P, et al. Occupational sun exposure and mycosis fungoides: a European multicenter case-control study. J Occup Environ Med. 2006;48(4):390-393.
15. van Leeuwen MT, Turner JJ, Falster MO, et al. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int J Cancer;133(4):944-951.
16. Gupta RK, Ramble J, Tong CY, Whittaker S, MacMahon E. Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides/Sezary syndrome. Blood. 2006;107(3):1241-1242.
17. Tothova SM, Bonin S, Trevisan G, Stanta G. Mycosis fungoides: is it a Borrelia burgdorferi-associated disease? Br J Cancer. 2006;94(6):879-883.
18. Trento E, Castilletti C, Ferraro C, et al. Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases. Arch Dermatol. 2005;141(10):1235-42.
19. Herne KL, Talpur R, Breuer-McHam J, Champlin R, Duvic M. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome. Blood. 2003;101(6):2132-2136.
20. de Sanjose S, Benavente Y, Vajdic CM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6(4):451-8.
21. Swerdlow SH, Campo E, Harris NL, et al., eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
22. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110(2):695-708.
23. Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116(20):e90-e98.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
25. Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83(1-2):148-156.
26. Morton LM, Hartge P, Holford TR, et al. Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (InterLymph). Cancer Epidemiol Biomarkers Prev. 2005;14(4):925-33.
27. Morales Suarez-Varela MM, Olsen J, Kaerlev L, et al. Are alcohol intake and smoking associated with mycosis fungoides? A European multicentre case-control study. Eur J Cancer. 2001;37(3):392-7.
28. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011;121(6):2111-2117.
29. Harris AW, Strasser A, Elefanty AG, Bath ML, Cory S. Deregulation of cell survival in lymphomagenesis. Leukemia. 1997;11(suppl 3):383-384.
30. Willett EV, Morton LM, Hartge P, et al. Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer. 2008;122(9):2062-70.
31. Ballard-Barbash R, Friedenreich C, Slattery M, Thune L. Obesity and body composition. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006.
32. Cerhan JR, Bernstein L, Severson RK, et al. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma. Cancer Causes Control. 2005;16(10):1203-1214.
33. Pan SY, Mao Y, Ugnat AM. Physical activity, obesity, energy intake, and the risk of non-Hodgkin's lymphoma: a population-based case-control study. Am J Epidemiol. 2005;162(12):1162-1173.
34. Burg G, Dummer R, Haeffner A, Kempf W, Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol. 2001;137(7):949-952.
35. Bellei B, Cota C, Amantea A, Muscardin L, Picardo M. Association of p53 Arg72Pro polymorphism and beta-catenin accumulation in mycosis fungoides. Br J Dermatol. 2006;155(6):1223-1229.
36. Skibola CF, Bracci PM, Nieters A, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol. 2010;171(3):267-276.
37. Wang SS, Slager SL, Brennan P, et al. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;109(8):3479-3488.
38. Alavanja MC, Bonner MR. Occupational pesticide exposures and cancer risk: a review. J Toxicol Environ Health B Crit Rev. 2012;15(4):238-263.
39. Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides and cancer. Cancer Causes Control. 1997;8(3):420-443.
40. Cocco P, Satta G, Dubois S, et al. Lymphoma risk and occupational exposure to pesticides: results of the Epilymph study. Occup Environ Med. 2013;70(2):91-98.
41. Kuzel TM, Roenigk HH Jr, Rosen ST. Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol. 1991;9(7):1298-1313.
42. Linet MS, McLaughlin JK, Malker HS, et al. Occupation and hematopoietic and lymphoproliferative malignancies among women: a linked registry study. J Occup Med. 1994;36(11):1187-1198.
43. Tuyp E, Burgoyne A, Aitchison T, MacKie R. A case-control study of possible causative factors in mycosis fungoides. Arch Dermatol. 1987;123(2):196-200.
44. Cocco P, t'Mannetje A, Fadda D, et al. Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case-control study. Occup Environ Med. 2010;67(5):341-7.
45. Cocco P, Vermeulen R, Flore V, et al. Occupational exposure to trichloroethylene and risk of non-Hodgkin lymphoma and its major subtypes: a pooled InterLlymph analysis. Occup Environ Med. 2013;70(11):795-802.